Do I have COVID-19 or is it something else? Bobby Tajudeen, MD, director of rhinology, sinus surgery and skull base surgery at Rush University Medical Center explains the differences between common smell loss and smell loss as a COVID-19 symptom and when to see a specialist.
Earlier this month, Baylor Scott & White Research Institute enrolled the first four patients in the world on Gilead’s new clinical trial involving an investigational inhaled solution of remdesivir (NCT04539262). This is Gilead’s first trial in COVID-19 patients examining the safety and efficacy of an inhaled solution of the drug in an outpatient setting. The study of an inhaled solution asks whether this mode of delivery can help reduce the amount of virus from the airways earlier.